Introduced to medical institutions nationwide approximately one year after launch. Japan's first "completely disposable" patch-type electrocardiograph receives commendation from the Furukawa Medical and Welfare Equipment Promotion Foundation.
NQ Score
100/100
AI Summary (NQ-processed)
Kokoromil Co., Ltd.'s "eclat," Japan's first completely disposable, 7-day continuous monitoring patch-type Holter electrocardiograph, has received a commendation in the social activity field from the Furukawa Medical and Welfare Equipment Promotion Foundation. The award recognizes "eclat" for its significant contributions to labor-saving in healthcare and reducing patient burden, addressing urgent issues like healthcare professional shortages and work style reforms in Japan. The device's rapid adoption and innovative features, such as its cordless design and mail-in return system, have been highly praised.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the name of the completely disposable patch-type electrocardiograph developed by Kokoromil Co., Ltd. that received an award in 2023?
- A: The device is called 'eclat,' Japan's first completely disposable, 7-day continuous monitoring patch-type Holter electrocardiograph.
- Q: Which organization awarded Kokoromil's 'eclat' a commendation for its contribution to medical and welfare equipment in Japan?
- A: The Furukawa Medical and Welfare Equipment Promotion Foundation awarded 'eclat' a commendation in the social activity field.
- Q: How many days of continuous monitoring does Kokoromil's 'eclat' device support for patients?
- A: The 'eclat' device supports 7-day continuous monitoring for patients using a completely disposable patch-type design.
- Q: What year did Kokoromil Co., Ltd. launch the 'eclat' device before its nationwide introduction to medical institutions?
- A: Kokoromil Co., Ltd. launched the 'eclat' device in 2022, with nationwide introduction to medical institutions approximately one year later.
- Q: What innovative feature of the 'eclat' device allows patients to return it without visiting a hospital after use?
- A: The 'eclat' device includes a mail-in return system, enabling patients to send the used patch back by post after monitoring.